Amniotic fluid insulin-like growth factor binding protein 3 concentration as early indicator of fetal growth restriction

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 144, Issue 1, 2009, Pages 15-20

  Murisier Petetin, Geraldine ^a   Gremlich, Sandrine ^a   Damnon, Francoise ^a   Reymondin, Danielle ^a   Hohlfeld, Patrick ^a   Gerber, Stefan ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Amniotic fluid; Fetal growth; Insulin like growth factor; Polymorphism

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AMNIOCENTESIS; AMNION FLUID; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LARGE FOR GESTATIONAL AGE; MAJOR CLINICAL STUDY; MALE; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 64149091908     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.01.004     Document Type: Article

References (30)

1. Rosenfeld R.G. Insulin-like growth factors and the basis of growth. N Engl J Med 349 (2003) 2184-2186
2. Monzavi R., and Cohen P. IGFs and IGFBPs: role in health and disease. Best Pract Res Clin Endocrinol Metab 16 (2002) 433-447
3. Holt R.I. Fetal programming of the growth hormone-insulin-like growth factor axis. Trends Endocrinol Metab 13 (2002) 392-397
4. Verhaeghe J., Pintiaux A., Van Herck E., et al. IGF-I, IGF-binding protein-1, and leptin during a glucose challenge test in pregnant women: relation with maternal body weight, glucose tolerance, and birth weight. J Clin Endocrinol Metab 87 (2002) 2875-2882
5. Dupont J., and Holzenberger M. Biology of insulin-like growth factors in development. Birth Defects Res C: Embryo Today 69 (2003) 257-271
6. Baker J., Liu J.P., Robertson E.J., and Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75 (1993) 73-82
7. DeChiara T.M., Robertson E.J., and Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64 (1991) 849-859
8. DeChiara T.M., Efstratiadis A., and Robertson E.J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345 (1990) 78-80
9. Ranjaram S., Baylink D.J., and Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 18 (1997) 801-831
10. Liu J.P., Baker J., Perkins A.S., Robertson E.J., and Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75 (1993) 59-72
11. Wang J., Zhou J., Powell-Braxton L., and Bondy C. Effects of Igf1 gene deletion on postnatal growth patterns. Endocrinology 140 (1999) 3391-3394
12. Domene H.M., Bengolea S.V., Jasper H.G., and Boisclair Y.R. Acid-labile subunit deficiency: phenotypic similarities and differences between human and mouse. J Endocrinol Invest 28 (2005) 43-46
13. Verhaeghe J., Coopmans W., van Herck E., van Schoubroeck D., Deprest J.A., and Witters L. IGF-I, IGF-II, IGF binding protein 1, and C-peptide in second trimester amniotic fluid are dependent on gestational age but do not predict weight at birth. Pediatr Res 46 (1999) 101-108
14. Roig M.D., Sabria J., Valls C., et al. The use of biochemical markers in prenatal diagnosis of intrauterine growth retardation: insulin-like growth factor I, leptin, and alpha-fetoprotein. Eur J Obstet Gynecol Reprod Biol 120 (2005) 27-32
15. Tisi D.K., Liu X.J., Wykes L.J., Skinner C.D., and Koski K.G. Insulin-like growth factor II and binding proteins 1 and 3 from second trimester human amniotic fluid are associated with infant birth weight. J Nutr 135 (2005) 1667-1672
16. Jensen R.B., Chellakooty M., Vielwerth S., et al. Intrauterine growth retardation and consequences for endocrine and cardiovascular diseases in adult life: does insulin-like growth factor-I play a role?. Horm Res 60 Suppl 3 (2003) 136-148
17. Rosen C.J., Kurland E.S., Vereault D., et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 83 (1998) 2286-2290
18. Vaessen N., Heutink P., Janssen J.A., Witteman J.C., Testers L., and Hofman A. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50 (2001) 637-642
19. Frayling T.M., Hattersley A.T., McCarthy A., et al. A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes 51 (2002) 2313-2316
20. Johnston L.B., Dahlgren J., Leger J., et al. Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestational age populations. J Clin Endocrinol Metab 88 (2003) 4805-4810
21. Jernstrom H., Deal C., Wilkin F., et al. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 10 (2001) 377-384
22. Deal C., Ma J., Wilkin F., et al. Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab 86 (2001) 1274-1280
23. Hohlfeld P, Marty F, De Grandi P, Tissot J-D, Bossart H, Gerber S. Obstétrique. Le livre de l′interne. 3rd ed. Paris (F): Flammarion Médecine-Sciences, 2004.
24. Adesina O.A., and Olayemi O. Fetal macrosomia at the University College Hospital, Ibadan: a 3-year review. J Obstet Gynaecol 23 (2003) 30-33
25. Stotland N.E., Caughey A.B., Breed E.M., and Escoba G.J. Risk factors and obstetric complications associated with macrosomia. Int J Gynecol Obstet 87 (2004) 220-226
26. Heinonen S., Taipale P., and Saarikoski S. Weights of placentae from small-for-gestational age infants revisited. Placenta 22 (2001) 399-404
27. Vaessen N., Janssen J.A., Heutink P., et al. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 359 (2002) 1036-1037
28. Morimoto L.M., Newcomb P.A., White E., Bigler J., and Potter J.D. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: genetic factors. Cancer Epidemiol Biomarkers Prev 14 (2005) 1394-1401
29. Modric T., Silha J.V., Shi Z., et al. Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. Endocrinology 142 (2001) 1958-1967
30. Ning Y., Schuller A.G., Bradshaw S., et al. Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5. Mol Endocrinol 20 (2006) 2173-2186